BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Similarly, autophagy is essential for degradation of BCR-ABL fusion protein by ATO in CML, and the inhibitory effects of ATO on colony-forming ability is reduced by lysosome inhibitors [40].